Gan02 0004 01
Chemical structure of ganciclovir sodium, shown as a molecular diagram with atoms and bonds illustrating its chemical composition.*
Ganciclovir Injection, Solution
Product Images NDC 25021-185
6 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 25021-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gan02 0004 02
Chemical structure of ganciclovir sodium showing the molecular arrangement of atoms and bonds in the active ingredient for this intravenous injection solution by Sagent Pharmaceuticals.*
Gan02 0004 03
A line graph titled 'ICM 1653: Time to Progression of CMV Retinitis' comparing intravenous (IV) and oral administration routes. The y-axis shows the proportion without progression, ranging from 0 to 1, and the x-axis presents time from start of maintenance therapy in days, up to 150 days. Two lines, one dashed (IV) and one solid (oral), illustrate the decrease in proportion without progression over time for each route.*
Gan02 0004 04
A line graph titled 'ICM 1774: Time to Progression of CMV Retinitis' comparing the proportion without progression over 120 days from the start of maintenance therapy for intravenous (IV) and oral treatments. The vertical axis shows the proportion without progression, and the horizontal axis represents time in days. The IV line (dashed) consistently shows higher proportions without progression compared to the oral line (solid).*
Gan02 0004 05
A line graph titled 'AVI 034: Time to Progression of CMV Retinitis' comparing the proportion without progression over time between intravenous (IV) and oral routes of administration. The x-axis represents time from start of maintenance therapy in days, and the y-axis shows the proportion without progression.*
Gan02 0004 06
Label for Ganciclovir Injection, 500 mg per 10 mL (50 mg/mL) single-dose vial by Sagent Pharmaceuticals. The label highlights the drug is a cytotoxic agent with cautionary warnings, includes storage instructions, and lists that each mL contains ganciclovir sodium equivalent to 50 mg ganciclovir in sterile solution.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
